nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC16A1—Methotrexate—hematologic cancer	0.0627	0.256	CbGbCtD
Niacin—CYP2D6—Lomustine—hematologic cancer	0.0345	0.141	CbGbCtD
Niacin—CYP2D6—Idarubicin—hematologic cancer	0.0307	0.125	CbGbCtD
Niacin—CYP2D6—Hydroxyurea—hematologic cancer	0.0261	0.107	CbGbCtD
Niacin—CYP2D6—Bortezomib—hematologic cancer	0.0227	0.0927	CbGbCtD
Niacin—CYP2D6—Imatinib—hematologic cancer	0.0167	0.0679	CbGbCtD
Niacin—HCAR3—hematopoietic system—hematologic cancer	0.0162	0.127	CbGeAlD
Niacin—CYP2D6—Nilotinib—hematologic cancer	0.0151	0.0617	CbGbCtD
Niacin—CYP2D6—Vinorelbine—hematologic cancer	0.015	0.0612	CbGbCtD
Niacin—HCAR3—blood—hematologic cancer	0.0107	0.0842	CbGeAlD
Niacin—HCAR2—hematopoietic system—hematologic cancer	0.0107	0.0842	CbGeAlD
Niacin—HCAR3—lung—hematologic cancer	0.00941	0.0738	CbGeAlD
Niacin—CYP2D6—Vinblastine—hematologic cancer	0.00925	0.0377	CbGbCtD
Niacin—HCAR2—blood—hematologic cancer	0.00711	0.0558	CbGeAlD
Niacin—CYP2D6—Dexamethasone—hematologic cancer	0.00685	0.0279	CbGbCtD
Niacin—HCAR2—lung—hematologic cancer	0.00623	0.0489	CbGeAlD
Niacin—NNMT—hematopoietic system—hematologic cancer	0.00603	0.0474	CbGeAlD
Niacin—HCAR2—testis—hematologic cancer	0.00588	0.0461	CbGeAlD
Niacin—CYP2D6—Doxorubicin—hematologic cancer	0.00568	0.0232	CbGbCtD
Niacin—HCAR2—lymph node—hematologic cancer	0.00426	0.0334	CbGeAlD
Niacin—Metyrapone—ABCC3—hematologic cancer	0.00424	0.878	CrCbGaD
Niacin—SLC16A3—hematopoietic system—hematologic cancer	0.00412	0.0324	CbGeAlD
Niacin—NNMT—bone marrow—hematologic cancer	0.00387	0.0304	CbGeAlD
Niacin—NNMT—lung—hematologic cancer	0.0035	0.0275	CbGeAlD
Niacin—NNMT—testis—hematologic cancer	0.00331	0.026	CbGeAlD
Niacin—SLC16A3—gonad—hematologic cancer	0.00313	0.0246	CbGeAlD
Niacin—SLC16A3—blood—hematologic cancer	0.00273	0.0214	CbGeAlD
Niacin—SLC16A3—bone marrow—hematologic cancer	0.00264	0.0207	CbGeAlD
Niacin—SLC16A1—hematopoietic system—hematologic cancer	0.0025	0.0197	CbGeAlD
Niacin—NNMT—lymph node—hematologic cancer	0.0024	0.0188	CbGeAlD
Niacin—SLC16A3—lung—hematologic cancer	0.00239	0.0188	CbGeAlD
Niacin—SLC16A3—testis—hematologic cancer	0.00226	0.0177	CbGeAlD
Niacin—SLCO2B1—hematopoietic system—hematologic cancer	0.00215	0.0169	CbGeAlD
Niacin—SLC16A1—gonad—hematologic cancer	0.0019	0.0149	CbGeAlD
Niacin—SLC16A3—lymph node—hematologic cancer	0.00164	0.0129	CbGeAlD
Niacin—SLC16A1—lung—hematologic cancer	0.00145	0.0114	CbGeAlD
Niacin—SLC16A1—testis—hematologic cancer	0.00137	0.0108	CbGeAlD
Niacin—SLC16A3—Azacitidine—Pentostatin—hematologic cancer	0.00126	0.192	CbGdCrCtD
Niacin—SLCO2B1—lung—hematologic cancer	0.00125	0.00982	CbGeAlD
Niacin—SLCO2B1—testis—hematologic cancer	0.00118	0.00927	CbGeAlD
Niacin—SLC16A3—Azacitidine—Clofarabine—hematologic cancer	0.00112	0.171	CbGdCrCtD
Niacin—SLC16A3—Azacitidine—Nelarabine—hematologic cancer	0.00106	0.161	CbGdCrCtD
Niacin—SLC16A1—lymph node—hematologic cancer	0.000995	0.00781	CbGeAlD
Niacin—SLC22A5—blood—hematologic cancer	0.000948	0.00744	CbGeAlD
Niacin—CYP2D6—hematopoietic system—hematologic cancer	0.000923	0.00725	CbGeAlD
Niacin—SLCO2B1—lymph node—hematologic cancer	0.000856	0.00672	CbGeAlD
Niacin—SLC22A5—lung—hematologic cancer	0.000831	0.00652	CbGeAlD
Niacin—SLC16A3—Azacitidine—Fludarabine—hematologic cancer	0.000825	0.125	CbGdCrCtD
Niacin—SLC22A5—testis—hematologic cancer	0.000784	0.00615	CbGeAlD
Niacin—SLC16A3—Azacitidine—Cytarabine—hematologic cancer	0.000779	0.118	CbGdCrCtD
Niacin—SLC16A3—Azacitidine—Gemcitabine—hematologic cancer	0.000779	0.118	CbGdCrCtD
Niacin—SLC16A3—Azacitidine—Cladribine—hematologic cancer	0.00076	0.115	CbGdCrCtD
Niacin—CYP2D6—blood—hematologic cancer	0.000612	0.0048	CbGeAlD
Niacin—SLC22A5—lymph node—hematologic cancer	0.000568	0.00446	CbGeAlD
Niacin—CYP2D6—testis—hematologic cancer	0.000506	0.00397	CbGeAlD
Niacin—Salicylic acid—ALB—hematologic cancer	0.000303	0.0627	CrCbGaD
Niacin—Salicylic acid—ABCB1—hematologic cancer	0.000289	0.0598	CrCbGaD
Niacin—Eye disorder—Epirubicin—hematologic cancer	4.1e-05	9.99e-05	CcSEcCtD
Niacin—Hypersensitivity—Etoposide—hematologic cancer	4.1e-05	9.98e-05	CcSEcCtD
Niacin—Tinnitus—Epirubicin—hematologic cancer	4.09e-05	9.97e-05	CcSEcCtD
Niacin—Erythema—Methotrexate—hematologic cancer	4.08e-05	9.94e-05	CcSEcCtD
Niacin—Malnutrition—Methotrexate—hematologic cancer	4.08e-05	9.94e-05	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—hematologic cancer	4.08e-05	9.94e-05	CcSEcCtD
Niacin—Headache—Gemcitabine—hematologic cancer	4.08e-05	9.94e-05	CcSEcCtD
Niacin—Nausea—Vincristine—hematologic cancer	4.08e-05	9.93e-05	CcSEcCtD
Niacin—Flushing—Epirubicin—hematologic cancer	4.08e-05	9.92e-05	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—hematologic cancer	4.07e-05	9.92e-05	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—hematologic cancer	4.06e-05	9.89e-05	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—hematologic cancer	4.06e-05	9.89e-05	CcSEcCtD
Niacin—Hypersensitivity—Prednisolone—hematologic cancer	4.04e-05	9.85e-05	CcSEcCtD
Niacin—Hypoaesthesia—Doxorubicin—hematologic cancer	4.04e-05	9.84e-05	CcSEcCtD
Niacin—Dyspepsia—Betamethasone—hematologic cancer	4.03e-05	9.82e-05	CcSEcCtD
Niacin—Dyspepsia—Dexamethasone—hematologic cancer	4.03e-05	9.82e-05	CcSEcCtD
Niacin—Urticaria—Triamcinolone—hematologic cancer	4.01e-05	9.76e-05	CcSEcCtD
Niacin—Oedema peripheral—Doxorubicin—hematologic cancer	4e-05	9.74e-05	CcSEcCtD
Niacin—Asthenia—Etoposide—hematologic cancer	3.99e-05	9.72e-05	CcSEcCtD
Niacin—Body temperature increased—Triamcinolone—hematologic cancer	3.99e-05	9.71e-05	CcSEcCtD
Niacin—Anaphylactic shock—Prednisone—hematologic cancer	3.99e-05	9.71e-05	CcSEcCtD
Niacin—Oedema—Prednisone—hematologic cancer	3.99e-05	9.71e-05	CcSEcCtD
Niacin—Angiopathy—Epirubicin—hematologic cancer	3.98e-05	9.7e-05	CcSEcCtD
Niacin—Decreased appetite—Dexamethasone—hematologic cancer	3.98e-05	9.69e-05	CcSEcCtD
Niacin—Decreased appetite—Betamethasone—hematologic cancer	3.98e-05	9.69e-05	CcSEcCtD
Niacin—Nausea—Irinotecan—hematologic cancer	3.97e-05	9.67e-05	CcSEcCtD
Niacin—Nausea—Mitoxantrone—hematologic cancer	3.97e-05	9.67e-05	CcSEcCtD
Niacin—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.95e-05	9.63e-05	CcSEcCtD
Niacin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.95e-05	9.63e-05	CcSEcCtD
Niacin—Chills—Epirubicin—hematologic cancer	3.94e-05	9.59e-05	CcSEcCtD
Niacin—Pruritus—Etoposide—hematologic cancer	3.94e-05	9.59e-05	CcSEcCtD
Niacin—Shock—Prednisone—hematologic cancer	3.92e-05	9.55e-05	CcSEcCtD
Niacin—Arrhythmia—Epirubicin—hematologic cancer	3.92e-05	9.55e-05	CcSEcCtD
Niacin—Pain—Betamethasone—hematologic cancer	3.92e-05	9.54e-05	CcSEcCtD
Niacin—Pain—Dexamethasone—hematologic cancer	3.92e-05	9.54e-05	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—hematologic cancer	3.92e-05	9.53e-05	CcSEcCtD
Niacin—Tachycardia—Prednisone—hematologic cancer	3.89e-05	9.48e-05	CcSEcCtD
Niacin—Alopecia—Epirubicin—hematologic cancer	3.88e-05	9.45e-05	CcSEcCtD
Niacin—Skin disorder—Prednisone—hematologic cancer	3.87e-05	9.43e-05	CcSEcCtD
Niacin—Nausea—Gemcitabine—hematologic cancer	3.87e-05	9.42e-05	CcSEcCtD
Niacin—Vomiting—Cisplatin—hematologic cancer	3.86e-05	9.4e-05	CcSEcCtD
Niacin—Hyperhidrosis—Prednisone—hematologic cancer	3.86e-05	9.39e-05	CcSEcCtD
Niacin—Vision blurred—Methotrexate—hematologic cancer	3.85e-05	9.37e-05	CcSEcCtD
Niacin—Rash—Cisplatin—hematologic cancer	3.83e-05	9.32e-05	CcSEcCtD
Niacin—Dermatitis—Cisplatin—hematologic cancer	3.83e-05	9.32e-05	CcSEcCtD
Niacin—Erythema—Epirubicin—hematologic cancer	3.82e-05	9.31e-05	CcSEcCtD
Niacin—Malnutrition—Epirubicin—hematologic cancer	3.82e-05	9.31e-05	CcSEcCtD
Niacin—Diarrhoea—Etoposide—hematologic cancer	3.81e-05	9.27e-05	CcSEcCtD
Niacin—Anorexia—Prednisone—hematologic cancer	3.8e-05	9.26e-05	CcSEcCtD
Niacin—Eye disorder—Doxorubicin—hematologic cancer	3.8e-05	9.24e-05	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—hematologic cancer	3.79e-05	9.22e-05	CcSEcCtD
Niacin—Flushing—Doxorubicin—hematologic cancer	3.77e-05	9.18e-05	CcSEcCtD
Niacin—Flatulence—Epirubicin—hematologic cancer	3.77e-05	9.17e-05	CcSEcCtD
Niacin—Tension—Epirubicin—hematologic cancer	3.75e-05	9.13e-05	CcSEcCtD
Niacin—Gastrointestinal pain—Betamethasone—hematologic cancer	3.75e-05	9.12e-05	CcSEcCtD
Niacin—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.75e-05	9.12e-05	CcSEcCtD
Niacin—Hypersensitivity—Triamcinolone—hematologic cancer	3.72e-05	9.05e-05	CcSEcCtD
Niacin—Nervousness—Epirubicin—hematologic cancer	3.71e-05	9.04e-05	CcSEcCtD
Niacin—Angiopathy—Doxorubicin—hematologic cancer	3.69e-05	8.97e-05	CcSEcCtD
Niacin—Dizziness—Etoposide—hematologic cancer	3.68e-05	8.96e-05	CcSEcCtD
Niacin—Muscle spasms—Epirubicin—hematologic cancer	3.67e-05	8.95e-05	CcSEcCtD
Niacin—Vertigo—Methotrexate—hematologic cancer	3.67e-05	8.93e-05	CcSEcCtD
Niacin—Leukopenia—Methotrexate—hematologic cancer	3.66e-05	8.9e-05	CcSEcCtD
Niacin—Chills—Doxorubicin—hematologic cancer	3.65e-05	8.87e-05	CcSEcCtD
Niacin—Urticaria—Betamethasone—hematologic cancer	3.64e-05	8.86e-05	CcSEcCtD
Niacin—Urticaria—Dexamethasone—hematologic cancer	3.64e-05	8.86e-05	CcSEcCtD
Niacin—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.63e-05	8.85e-05	CcSEcCtD
Niacin—Dizziness—Prednisolone—hematologic cancer	3.63e-05	8.84e-05	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—hematologic cancer	3.63e-05	8.84e-05	CcSEcCtD
Niacin—Asthenia—Triamcinolone—hematologic cancer	3.62e-05	8.82e-05	CcSEcCtD
Niacin—Abdominal pain—Betamethasone—hematologic cancer	3.62e-05	8.81e-05	CcSEcCtD
Niacin—Abdominal pain—Dexamethasone—hematologic cancer	3.62e-05	8.81e-05	CcSEcCtD
Niacin—Body temperature increased—Dexamethasone—hematologic cancer	3.62e-05	8.81e-05	CcSEcCtD
Niacin—Body temperature increased—Betamethasone—hematologic cancer	3.62e-05	8.81e-05	CcSEcCtD
Niacin—Nausea—Cisplatin—hematologic cancer	3.61e-05	8.78e-05	CcSEcCtD
Niacin—Insomnia—Prednisone—hematologic cancer	3.61e-05	8.78e-05	CcSEcCtD
Niacin—Vision blurred—Epirubicin—hematologic cancer	3.6e-05	8.77e-05	CcSEcCtD
Niacin—Alopecia—Doxorubicin—hematologic cancer	3.59e-05	8.74e-05	CcSEcCtD
Niacin—Paraesthesia—Prednisone—hematologic cancer	3.58e-05	8.72e-05	CcSEcCtD
Niacin—Pruritus—Triamcinolone—hematologic cancer	3.57e-05	8.69e-05	CcSEcCtD
Niacin—Cough—Methotrexate—hematologic cancer	3.56e-05	8.68e-05	CcSEcCtD
Niacin—Vomiting—Etoposide—hematologic cancer	3.54e-05	8.61e-05	CcSEcCtD
Niacin—Erythema—Doxorubicin—hematologic cancer	3.54e-05	8.61e-05	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—hematologic cancer	3.54e-05	8.61e-05	CcSEcCtD
Niacin—Dyspepsia—Prednisone—hematologic cancer	3.51e-05	8.55e-05	CcSEcCtD
Niacin—Rash—Etoposide—hematologic cancer	3.51e-05	8.54e-05	CcSEcCtD
Niacin—Dermatitis—Etoposide—hematologic cancer	3.51e-05	8.53e-05	CcSEcCtD
Niacin—Headache—Etoposide—hematologic cancer	3.49e-05	8.49e-05	CcSEcCtD
Niacin—Flatulence—Doxorubicin—hematologic cancer	3.49e-05	8.48e-05	CcSEcCtD
Niacin—Arthralgia—Methotrexate—hematologic cancer	3.48e-05	8.47e-05	CcSEcCtD
Niacin—Myalgia—Methotrexate—hematologic cancer	3.48e-05	8.47e-05	CcSEcCtD
Niacin—Tension—Doxorubicin—hematologic cancer	3.47e-05	8.45e-05	CcSEcCtD
Niacin—Decreased appetite—Prednisone—hematologic cancer	3.47e-05	8.44e-05	CcSEcCtD
Niacin—Rash—Prednisolone—hematologic cancer	3.46e-05	8.43e-05	CcSEcCtD
Niacin—Dermatitis—Prednisolone—hematologic cancer	3.46e-05	8.42e-05	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.45e-05	8.41e-05	CcSEcCtD
Niacin—Headache—Prednisolone—hematologic cancer	3.44e-05	8.37e-05	CcSEcCtD
Niacin—Nervousness—Doxorubicin—hematologic cancer	3.44e-05	8.36e-05	CcSEcCtD
Niacin—Vertigo—Epirubicin—hematologic cancer	3.43e-05	8.36e-05	CcSEcCtD
Niacin—Syncope—Epirubicin—hematologic cancer	3.43e-05	8.34e-05	CcSEcCtD
Niacin—Leukopenia—Epirubicin—hematologic cancer	3.42e-05	8.33e-05	CcSEcCtD
Niacin—Muscle spasms—Doxorubicin—hematologic cancer	3.4e-05	8.28e-05	CcSEcCtD
Niacin—Palpitations—Epirubicin—hematologic cancer	3.38e-05	8.22e-05	CcSEcCtD
Niacin—Loss of consciousness—Epirubicin—hematologic cancer	3.36e-05	8.18e-05	CcSEcCtD
Niacin—Dizziness—Triamcinolone—hematologic cancer	3.34e-05	8.13e-05	CcSEcCtD
Niacin—Cough—Epirubicin—hematologic cancer	3.34e-05	8.12e-05	CcSEcCtD
Niacin—Anaphylactic shock—Methotrexate—hematologic cancer	3.33e-05	8.12e-05	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—hematologic cancer	3.33e-05	8.11e-05	CcSEcCtD
Niacin—Nausea—Etoposide—hematologic cancer	3.31e-05	8.05e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—IL6R—hematologic cancer	3.29e-05	0.00016	CbGpPWpGaD
Niacin—Asthenia—Betamethasone—hematologic cancer	3.29e-05	8e-05	CcSEcCtD
Niacin—Asthenia—Dexamethasone—hematologic cancer	3.29e-05	8e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CREBBP—hematologic cancer	3.28e-05	0.00016	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—IDH1—hematologic cancer	3.28e-05	0.00016	CbGpPWpGaD
Niacin—QPRT—Disease—MAPK3—hematologic cancer	3.27e-05	0.00016	CbGpPWpGaD
Niacin—Gastrointestinal pain—Prednisone—hematologic cancer	3.26e-05	7.94e-05	CcSEcCtD
Niacin—Nausea—Prednisolone—hematologic cancer	3.26e-05	7.94e-05	CcSEcCtD
Niacin—Arthralgia—Epirubicin—hematologic cancer	3.25e-05	7.92e-05	CcSEcCtD
Niacin—Myalgia—Epirubicin—hematologic cancer	3.25e-05	7.92e-05	CcSEcCtD
Niacin—SLC16A3—Hemostasis—VEGFA—hematologic cancer	3.24e-05	0.000158	CbGpPWpGaD
Niacin—Pruritus—Dexamethasone—hematologic cancer	3.24e-05	7.89e-05	CcSEcCtD
Niacin—Pruritus—Betamethasone—hematologic cancer	3.24e-05	7.89e-05	CcSEcCtD
Niacin—SLC16A1—Metabolism—ABCC3—hematologic cancer	3.24e-05	0.000158	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTO1—hematologic cancer	3.24e-05	0.000158	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TXN—hematologic cancer	3.24e-05	0.000158	CbGpPWpGaD
Niacin—Skin disorder—Methotrexate—hematologic cancer	3.24e-05	7.88e-05	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.23e-05	7.87e-05	CcSEcCtD
Niacin—SLC16A3—Metabolism—GSTP1—hematologic cancer	3.22e-05	0.000157	CbGpPWpGaD
Niacin—Hyperhidrosis—Methotrexate—hematologic cancer	3.22e-05	7.85e-05	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—MAPK3—hematologic cancer	3.21e-05	0.000157	CbGpPWpGaD
Niacin—Vomiting—Triamcinolone—hematologic cancer	3.21e-05	7.81e-05	CcSEcCtD
Niacin—QPRT—Metabolism—PTEN—hematologic cancer	3.21e-05	0.000156	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NRAS—hematologic cancer	3.2e-05	0.000156	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CREB1—hematologic cancer	3.2e-05	0.000156	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—hematologic cancer	3.18e-05	0.000155	CbGpPWpGaD
Niacin—Rash—Triamcinolone—hematologic cancer	3.18e-05	7.75e-05	CcSEcCtD
Niacin—Dry mouth—Epirubicin—hematologic cancer	3.18e-05	7.75e-05	CcSEcCtD
Niacin—Dermatitis—Triamcinolone—hematologic cancer	3.18e-05	7.74e-05	CcSEcCtD
Niacin—Vertigo—Doxorubicin—hematologic cancer	3.18e-05	7.74e-05	CcSEcCtD
Niacin—Anorexia—Methotrexate—hematologic cancer	3.18e-05	7.74e-05	CcSEcCtD
Niacin—QPRT—Disease—TGFB1—hematologic cancer	3.18e-05	0.000155	CbGpPWpGaD
Niacin—Syncope—Doxorubicin—hematologic cancer	3.17e-05	7.72e-05	CcSEcCtD
Niacin—SLC16A1—Metabolism—SPHK1—hematologic cancer	3.17e-05	0.000155	CbGpPWpGaD
Niacin—Urticaria—Prednisone—hematologic cancer	3.17e-05	7.71e-05	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—hematologic cancer	3.17e-05	7.71e-05	CcSEcCtD
Niacin—Headache—Triamcinolone—hematologic cancer	3.16e-05	7.7e-05	CcSEcCtD
Niacin—SLC16A1—Hemostasis—MAPK14—hematologic cancer	3.16e-05	0.000154	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—BRAF—hematologic cancer	3.16e-05	0.000154	CbGpPWpGaD
Niacin—Body temperature increased—Prednisone—hematologic cancer	3.15e-05	7.68e-05	CcSEcCtD
Niacin—Abdominal pain—Prednisone—hematologic cancer	3.15e-05	7.68e-05	CcSEcCtD
Niacin—Diarrhoea—Betamethasone—hematologic cancer	3.13e-05	7.63e-05	CcSEcCtD
Niacin—Diarrhoea—Dexamethasone—hematologic cancer	3.13e-05	7.63e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—MAP2K1—hematologic cancer	3.13e-05	0.000153	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCL2—hematologic cancer	3.13e-05	0.000152	CbGpPWpGaD
Niacin—Palpitations—Doxorubicin—hematologic cancer	3.13e-05	7.61e-05	CcSEcCtD
Niacin—Anaphylactic shock—Epirubicin—hematologic cancer	3.12e-05	7.59e-05	CcSEcCtD
Niacin—Oedema—Epirubicin—hematologic cancer	3.12e-05	7.59e-05	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—IL6R—hematologic cancer	3.12e-05	0.000152	CbGpPWpGaD
Niacin—Hypotension—Methotrexate—hematologic cancer	3.11e-05	7.58e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PIK3CD—hematologic cancer	3.11e-05	0.000152	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CREBBP—hematologic cancer	3.11e-05	0.000152	CbGpPWpGaD
Niacin—Loss of consciousness—Doxorubicin—hematologic cancer	3.11e-05	7.57e-05	CcSEcCtD
Niacin—Cough—Doxorubicin—hematologic cancer	3.09e-05	7.51e-05	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—hematologic cancer	3.08e-05	0.00015	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—MAPK3—hematologic cancer	3.07e-05	0.00015	CbGpPWpGaD
Niacin—Shock—Epirubicin—hematologic cancer	3.07e-05	7.47e-05	CcSEcCtD
Niacin—SLC16A1—Hemostasis—FN1—hematologic cancer	3.06e-05	0.000149	CbGpPWpGaD
Niacin—QPRT—Metabolism—EP300—hematologic cancer	3.06e-05	0.000149	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ABCB1—hematologic cancer	3.05e-05	0.000149	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—hematologic cancer	3.05e-05	0.000149	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—UGT1A1—hematologic cancer	3.05e-05	0.000149	CbGpPWpGaD
Niacin—Tachycardia—Epirubicin—hematologic cancer	3.04e-05	7.41e-05	CcSEcCtD
Niacin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.04e-05	7.39e-05	CcSEcCtD
Niacin—Skin disorder—Epirubicin—hematologic cancer	3.03e-05	7.38e-05	CcSEcCtD
Niacin—Dizziness—Dexamethasone—hematologic cancer	3.03e-05	7.37e-05	CcSEcCtD
Niacin—Dizziness—Betamethasone—hematologic cancer	3.03e-05	7.37e-05	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.03e-05	0.000148	CbGpPWpGaD
Niacin—Hyperhidrosis—Epirubicin—hematologic cancer	3.02e-05	7.34e-05	CcSEcCtD
Niacin—Insomnia—Methotrexate—hematologic cancer	3.02e-05	7.34e-05	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—hematologic cancer	3.01e-05	7.33e-05	CcSEcCtD
Niacin—Myalgia—Doxorubicin—hematologic cancer	3.01e-05	7.33e-05	CcSEcCtD
Niacin—Nausea—Triamcinolone—hematologic cancer	3e-05	7.3e-05	CcSEcCtD
Niacin—Paraesthesia—Methotrexate—hematologic cancer	2.99e-05	7.29e-05	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.99e-05	7.28e-05	CcSEcCtD
Niacin—NNMT—Metabolism—PTEN—hematologic cancer	2.98e-05	0.000145	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FGF2—hematologic cancer	2.98e-05	0.000145	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TGFB1—hematologic cancer	2.98e-05	0.000145	CbGpPWpGaD
Niacin—Anorexia—Epirubicin—hematologic cancer	2.97e-05	7.24e-05	CcSEcCtD
Niacin—Dyspnoea—Methotrexate—hematologic cancer	2.97e-05	7.24e-05	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—MAP2K1—hematologic cancer	2.97e-05	0.000145	CbGpPWpGaD
Niacin—Somnolence—Methotrexate—hematologic cancer	2.96e-05	7.21e-05	CcSEcCtD
Niacin—SLC16A1—Metabolism—CRABP1—hematologic cancer	2.96e-05	0.000144	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC22A1—hematologic cancer	2.96e-05	0.000144	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NCOR1—hematologic cancer	2.96e-05	0.000144	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTM1—hematologic cancer	2.96e-05	0.000144	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CD—hematologic cancer	2.95e-05	0.000144	CbGpPWpGaD
Niacin—Dry mouth—Doxorubicin—hematologic cancer	2.94e-05	7.17e-05	CcSEcCtD
Niacin—QPRT—Disease—KRAS—hematologic cancer	2.94e-05	0.000143	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3R1—hematologic cancer	2.94e-05	0.000143	CbGpPWpGaD
Niacin—Hypersensitivity—Prednisone—hematologic cancer	2.94e-05	7.15e-05	CcSEcCtD
Niacin—Dyspepsia—Methotrexate—hematologic cancer	2.93e-05	7.14e-05	CcSEcCtD
Niacin—SLC16A1—Hemostasis—PIK3CG—hematologic cancer	2.93e-05	0.000143	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—hematologic cancer	2.92e-05	0.000143	CbGpPWpGaD
Niacin—Hypotension—Epirubicin—hematologic cancer	2.92e-05	7.1e-05	CcSEcCtD
Niacin—Vomiting—Dexamethasone—hematologic cancer	2.91e-05	7.09e-05	CcSEcCtD
Niacin—Vomiting—Betamethasone—hematologic cancer	2.91e-05	7.09e-05	CcSEcCtD
Niacin—Decreased appetite—Methotrexate—hematologic cancer	2.9e-05	7.05e-05	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—KRAS—hematologic cancer	2.89e-05	0.000141	CbGpPWpGaD
Niacin—Rash—Betamethasone—hematologic cancer	2.89e-05	7.03e-05	CcSEcCtD
Niacin—Rash—Dexamethasone—hematologic cancer	2.89e-05	7.03e-05	CcSEcCtD
Niacin—SLC16A1—Metabolism—ALOX5—hematologic cancer	2.89e-05	0.000141	CbGpPWpGaD
Niacin—Oedema—Doxorubicin—hematologic cancer	2.89e-05	7.03e-05	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—hematologic cancer	2.89e-05	7.03e-05	CcSEcCtD
Niacin—Dermatitis—Dexamethasone—hematologic cancer	2.89e-05	7.02e-05	CcSEcCtD
Niacin—Dermatitis—Betamethasone—hematologic cancer	2.89e-05	7.02e-05	CcSEcCtD
Niacin—SLC16A1—Hemostasis—PTPN11—hematologic cancer	2.88e-05	0.00014	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.88e-05	7.01e-05	CcSEcCtD
Niacin—Headache—Dexamethasone—hematologic cancer	2.87e-05	6.99e-05	CcSEcCtD
Niacin—Headache—Betamethasone—hematologic cancer	2.87e-05	6.99e-05	CcSEcCtD
Niacin—Asthenia—Prednisone—hematologic cancer	2.86e-05	6.97e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—JAK2—hematologic cancer	2.86e-05	0.000139	CbGpPWpGaD
Niacin—Pain—Methotrexate—hematologic cancer	2.85e-05	6.94e-05	CcSEcCtD
Niacin—NNMT—Metabolism—EP300—hematologic cancer	2.84e-05	0.000139	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.84e-05	6.92e-05	CcSEcCtD
Niacin—Shock—Doxorubicin—hematologic cancer	2.84e-05	6.91e-05	CcSEcCtD
Niacin—CYP2D6—Biological oxidations—GSTP1—hematologic cancer	2.84e-05	0.000138	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FGF2—hematologic cancer	2.83e-05	0.000138	CbGpPWpGaD
Niacin—Pruritus—Prednisone—hematologic cancer	2.82e-05	6.87e-05	CcSEcCtD
Niacin—Insomnia—Epirubicin—hematologic cancer	2.82e-05	6.87e-05	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—hematologic cancer	2.82e-05	6.86e-05	CcSEcCtD
Niacin—Skin disorder—Doxorubicin—hematologic cancer	2.8e-05	6.83e-05	CcSEcCtD
Niacin—Paraesthesia—Epirubicin—hematologic cancer	2.8e-05	6.82e-05	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—hematologic cancer	2.8e-05	0.000137	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTP1—hematologic cancer	2.8e-05	0.000136	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NUP98—hematologic cancer	2.8e-05	0.000136	CbGpPWpGaD
Niacin—Hyperhidrosis—Doxorubicin—hematologic cancer	2.79e-05	6.79e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—MDM2—hematologic cancer	2.79e-05	0.000136	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3R1—hematologic cancer	2.79e-05	0.000136	CbGpPWpGaD
Niacin—Dyspnoea—Epirubicin—hematologic cancer	2.78e-05	6.77e-05	CcSEcCtD
Niacin—Somnolence—Epirubicin—hematologic cancer	2.77e-05	6.75e-05	CcSEcCtD
Niacin—SLC16A3—Hemostasis—KRAS—hematologic cancer	2.76e-05	0.000135	CbGpPWpGaD
Niacin—Anorexia—Doxorubicin—hematologic cancer	2.75e-05	6.7e-05	CcSEcCtD
Niacin—Dyspepsia—Epirubicin—hematologic cancer	2.75e-05	6.69e-05	CcSEcCtD
Niacin—Diarrhoea—Prednisone—hematologic cancer	2.73e-05	6.64e-05	CcSEcCtD
Niacin—Gastrointestinal pain—Methotrexate—hematologic cancer	2.73e-05	6.64e-05	CcSEcCtD
Niacin—Nausea—Betamethasone—hematologic cancer	2.72e-05	6.62e-05	CcSEcCtD
Niacin—Nausea—Dexamethasone—hematologic cancer	2.72e-05	6.62e-05	CcSEcCtD
Niacin—SLC16A1—Hemostasis—CREBBP—hematologic cancer	2.72e-05	0.000132	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ADCY7—hematologic cancer	2.71e-05	0.000132	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOA3—hematologic cancer	2.71e-05	0.000132	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MTOR—hematologic cancer	2.71e-05	0.000132	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CB—hematologic cancer	2.71e-05	0.000132	CbGpPWpGaD
Niacin—Decreased appetite—Epirubicin—hematologic cancer	2.71e-05	6.6e-05	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—JAK2—hematologic cancer	2.71e-05	0.000132	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—hematologic cancer	2.7e-05	0.000132	CbGpPWpGaD
Niacin—Hypotension—Doxorubicin—hematologic cancer	2.7e-05	6.57e-05	CcSEcCtD
Niacin—SLC16A1—Metabolism—NUP214—hematologic cancer	2.7e-05	0.000131	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.69e-05	6.56e-05	CcSEcCtD
Niacin—Pain—Epirubicin—hematologic cancer	2.67e-05	6.49e-05	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—hematologic cancer	2.65e-05	0.000129	CbGpPWpGaD
Niacin—Urticaria—Methotrexate—hematologic cancer	2.65e-05	6.45e-05	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.65e-05	0.000129	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MDM2—hematologic cancer	2.64e-05	0.000129	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTR—hematologic cancer	2.64e-05	0.000129	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCG2—hematologic cancer	2.64e-05	0.000129	CbGpPWpGaD
Niacin—Dizziness—Prednisone—hematologic cancer	2.64e-05	6.42e-05	CcSEcCtD
Niacin—Body temperature increased—Methotrexate—hematologic cancer	2.64e-05	6.42e-05	CcSEcCtD
Niacin—Abdominal pain—Methotrexate—hematologic cancer	2.64e-05	6.42e-05	CcSEcCtD
Niacin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.63e-05	6.4e-05	CcSEcCtD
Niacin—SLC16A3—Metabolism—MTHFR—hematologic cancer	2.62e-05	0.000128	CbGpPWpGaD
Niacin—Insomnia—Doxorubicin—hematologic cancer	2.61e-05	6.36e-05	CcSEcCtD
Niacin—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	2.61e-05	0.000127	CbGpPWpGaD
Niacin—Paraesthesia—Doxorubicin—hematologic cancer	2.59e-05	6.31e-05	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—HRAS—hematologic cancer	2.59e-05	0.000126	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ENO2—hematologic cancer	2.59e-05	0.000126	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CD—hematologic cancer	2.58e-05	0.000126	CbGpPWpGaD
Niacin—Dyspnoea—Doxorubicin—hematologic cancer	2.57e-05	6.26e-05	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—MTOR—hematologic cancer	2.57e-05	0.000125	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CB—hematologic cancer	2.57e-05	0.000125	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	2.57e-05	0.000125	CbGpPWpGaD
Niacin—Somnolence—Doxorubicin—hematologic cancer	2.57e-05	6.25e-05	CcSEcCtD
Niacin—Gastrointestinal pain—Epirubicin—hematologic cancer	2.55e-05	6.21e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CDKN1B—hematologic cancer	2.55e-05	0.000124	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—hematologic cancer	2.54e-05	0.000124	CbGpPWpGaD
Niacin—Dyspepsia—Doxorubicin—hematologic cancer	2.54e-05	6.19e-05	CcSEcCtD
Niacin—Vomiting—Prednisone—hematologic cancer	2.54e-05	6.17e-05	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PIK3CA—hematologic cancer	2.53e-05	0.000124	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—hematologic cancer	2.52e-05	0.000123	CbGpPWpGaD
Niacin—Rash—Prednisone—hematologic cancer	2.51e-05	6.12e-05	CcSEcCtD
Niacin—Dermatitis—Prednisone—hematologic cancer	2.51e-05	6.12e-05	CcSEcCtD
Niacin—SLC16A1—Metabolism—GSTT1—hematologic cancer	2.51e-05	0.000122	CbGpPWpGaD
Niacin—Decreased appetite—Doxorubicin—hematologic cancer	2.51e-05	6.11e-05	CcSEcCtD
Niacin—QPRT—Disease—HRAS—hematologic cancer	2.5e-05	0.000122	CbGpPWpGaD
Niacin—Headache—Prednisone—hematologic cancer	2.5e-05	6.08e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CASP3—hematologic cancer	2.5e-05	0.000122	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.49e-05	6.07e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—IL2—hematologic cancer	2.49e-05	0.000122	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—hematologic cancer	2.48e-05	0.000121	CbGpPWpGaD
Niacin—Urticaria—Epirubicin—hematologic cancer	2.48e-05	6.03e-05	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.48e-05	0.000121	CbGpPWpGaD
Niacin—Pain—Doxorubicin—hematologic cancer	2.47e-05	6.01e-05	CcSEcCtD
Niacin—Body temperature increased—Epirubicin—hematologic cancer	2.47e-05	6e-05	CcSEcCtD
Niacin—Abdominal pain—Epirubicin—hematologic cancer	2.47e-05	6e-05	CcSEcCtD
Niacin—Hypersensitivity—Methotrexate—hematologic cancer	2.46e-05	5.98e-05	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—HRAS—hematologic cancer	2.46e-05	0.00012	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SDC1—hematologic cancer	2.45e-05	0.00012	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—hematologic cancer	2.45e-05	0.00012	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3R1—hematologic cancer	2.43e-05	0.000119	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—hematologic cancer	2.43e-05	0.000118	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—JUN—hematologic cancer	2.42e-05	0.000118	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1B—hematologic cancer	2.41e-05	0.000118	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—hematologic cancer	2.39e-05	0.000117	CbGpPWpGaD
Niacin—Asthenia—Methotrexate—hematologic cancer	2.39e-05	5.82e-05	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—AKT1—hematologic cancer	2.39e-05	0.000116	CbGpPWpGaD
Niacin—Nausea—Prednisone—hematologic cancer	2.37e-05	5.77e-05	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CASP3—hematologic cancer	2.37e-05	0.000115	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—JAK2—hematologic cancer	2.36e-05	0.000115	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—hematologic cancer	2.36e-05	0.000115	CbGpPWpGaD
Niacin—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.36e-05	5.75e-05	CcSEcCtD
Niacin—Pruritus—Methotrexate—hematologic cancer	2.36e-05	5.74e-05	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.35e-05	0.000115	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—hematologic cancer	2.35e-05	0.000115	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1A—hematologic cancer	2.35e-05	0.000115	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—hematologic cancer	2.34e-05	0.000114	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—hematologic cancer	2.34e-05	0.000114	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—hematologic cancer	2.3e-05	0.000112	CbGpPWpGaD
Niacin—Hypersensitivity—Epirubicin—hematologic cancer	2.3e-05	5.6e-05	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—JUN—hematologic cancer	2.3e-05	0.000112	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK8—hematologic cancer	2.29e-05	0.000112	CbGpPWpGaD
Niacin—Urticaria—Doxorubicin—hematologic cancer	2.29e-05	5.58e-05	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—AKT1—hematologic cancer	2.29e-05	0.000112	CbGpPWpGaD
Niacin—Body temperature increased—Doxorubicin—hematologic cancer	2.28e-05	5.56e-05	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—hematologic cancer	2.28e-05	5.56e-05	CcSEcCtD
Niacin—Diarrhoea—Methotrexate—hematologic cancer	2.28e-05	5.55e-05	CcSEcCtD
Niacin—QPRT—Metabolism—PIK3CA—hematologic cancer	2.26e-05	0.00011	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CB—hematologic cancer	2.24e-05	0.000109	CbGpPWpGaD
Niacin—Asthenia—Epirubicin—hematologic cancer	2.24e-05	5.45e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—EP300—hematologic cancer	2.24e-05	0.000109	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1A—hematologic cancer	2.23e-05	0.000109	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—hematologic cancer	2.22e-05	0.000108	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—hematologic cancer	2.21e-05	0.000108	CbGpPWpGaD
Niacin—Pruritus—Epirubicin—hematologic cancer	2.21e-05	5.37e-05	CcSEcCtD
Niacin—Dizziness—Methotrexate—hematologic cancer	2.2e-05	5.37e-05	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.2e-05	0.000107	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—hematologic cancer	2.2e-05	0.000107	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK8—hematologic cancer	2.17e-05	0.000106	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SRC—hematologic cancer	2.17e-05	0.000106	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GMPS—hematologic cancer	2.17e-05	0.000106	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FTCD—hematologic cancer	2.17e-05	0.000106	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PHYH—hematologic cancer	2.17e-05	0.000106	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—hematologic cancer	2.17e-05	0.000106	CbGpPWpGaD
Niacin—Diarrhoea—Epirubicin—hematologic cancer	2.13e-05	5.2e-05	CcSEcCtD
Niacin—Hypersensitivity—Doxorubicin—hematologic cancer	2.13e-05	5.18e-05	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—EP300—hematologic cancer	2.12e-05	0.000103	CbGpPWpGaD
Niacin—Vomiting—Methotrexate—hematologic cancer	2.12e-05	5.16e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—VEGFA—hematologic cancer	2.12e-05	0.000103	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—hematologic cancer	2.1e-05	0.000103	CbGpPWpGaD
Niacin—Rash—Methotrexate—hematologic cancer	2.1e-05	5.12e-05	CcSEcCtD
Niacin—Dermatitis—Methotrexate—hematologic cancer	2.1e-05	5.11e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—STAT3—hematologic cancer	2.1e-05	0.000102	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NRAS—hematologic cancer	2.09e-05	0.000102	CbGpPWpGaD
Niacin—Headache—Methotrexate—hematologic cancer	2.09e-05	5.08e-05	CcSEcCtD
Niacin—SLC16A1—Metabolism—NQO1—hematologic cancer	2.09e-05	0.000102	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CD44—hematologic cancer	2.09e-05	0.000102	CbGpPWpGaD
Niacin—Asthenia—Doxorubicin—hematologic cancer	2.07e-05	5.04e-05	CcSEcCtD
Niacin—SLC16A3—Hemostasis—AKT1—hematologic cancer	2.07e-05	0.000101	CbGpPWpGaD
Niacin—Dizziness—Epirubicin—hematologic cancer	2.06e-05	5.02e-05	CcSEcCtD
Niacin—SLC16A1—Hemostasis—IL2—hematologic cancer	2.06e-05	0.000101	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SRC—hematologic cancer	2.06e-05	0.000101	CbGpPWpGaD
Niacin—Pruritus—Doxorubicin—hematologic cancer	2.04e-05	4.97e-05	CcSEcCtD
Niacin—SLC16A3—Metabolism—CREBBP—hematologic cancer	2.04e-05	9.95e-05	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.02e-05	9.86e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—hematologic cancer	2.01e-05	9.79e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK3—hematologic cancer	2e-05	9.77e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—hematologic cancer	1.99e-05	9.69e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SMPD3—hematologic cancer	1.99e-05	9.69e-05	CbGpPWpGaD
Niacin—Vomiting—Epirubicin—hematologic cancer	1.98e-05	4.83e-05	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—NRAS—hematologic cancer	1.98e-05	9.67e-05	CbGpPWpGaD
Niacin—Nausea—Methotrexate—hematologic cancer	1.98e-05	4.82e-05	CcSEcCtD
Niacin—SLC16A1—Metabolism—CYCS—hematologic cancer	1.98e-05	9.63e-05	CbGpPWpGaD
Niacin—Diarrhoea—Doxorubicin—hematologic cancer	1.97e-05	4.81e-05	CcSEcCtD
Niacin—Rash—Epirubicin—hematologic cancer	1.97e-05	4.79e-05	CcSEcCtD
Niacin—Dermatitis—Epirubicin—hematologic cancer	1.97e-05	4.78e-05	CcSEcCtD
Niacin—SLC16A1—Metabolism—HSP90AA1—hematologic cancer	1.96e-05	9.57e-05	CbGpPWpGaD
Niacin—Headache—Epirubicin—hematologic cancer	1.95e-05	4.76e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—MYC—hematologic cancer	1.95e-05	9.5e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—hematologic cancer	1.94e-05	9.48e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CD—hematologic cancer	1.93e-05	9.43e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—hematologic cancer	1.91e-05	9.31e-05	CbGpPWpGaD
Niacin—Dizziness—Doxorubicin—hematologic cancer	1.91e-05	4.65e-05	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—MAPK3—hematologic cancer	1.9e-05	9.26e-05	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.89e-05	9.23e-05	CbGpPWpGaD
Niacin—Nausea—Epirubicin—hematologic cancer	1.85e-05	4.51e-05	CcSEcCtD
Niacin—SLC16A1—Hemostasis—EP300—hematologic cancer	1.85e-05	9.02e-05	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—hematologic cancer	1.85e-05	9.02e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—hematologic cancer	1.85e-05	9.01e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—hematologic cancer	1.84e-05	8.99e-05	CbGpPWpGaD
Niacin—Vomiting—Doxorubicin—hematologic cancer	1.84e-05	4.47e-05	CcSEcCtD
Niacin—SLC16A3—Metabolism—PIK3R1—hematologic cancer	1.83e-05	8.9e-05	CbGpPWpGaD
Niacin—Rash—Doxorubicin—hematologic cancer	1.82e-05	4.43e-05	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—hematologic cancer	1.82e-05	4.43e-05	CcSEcCtD
Niacin—Headache—Doxorubicin—hematologic cancer	1.81e-05	4.4e-05	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—KRAS—hematologic cancer	1.8e-05	8.78e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SRC—hematologic cancer	1.8e-05	8.77e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—hematologic cancer	1.75e-05	8.54e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTP1—hematologic cancer	1.74e-05	8.49e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ASNS—hematologic cancer	1.74e-05	8.47e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—DCK—hematologic cancer	1.74e-05	8.47e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—B3GAT1—hematologic cancer	1.74e-05	8.47e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NRAS—hematologic cancer	1.73e-05	8.44e-05	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—hematologic cancer	1.72e-05	8.38e-05	CbGpPWpGaD
Niacin—Nausea—Doxorubicin—hematologic cancer	1.71e-05	4.17e-05	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—KRAS—hematologic cancer	1.71e-05	8.32e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CB—hematologic cancer	1.69e-05	8.22e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK3—hematologic cancer	1.66e-05	8.08e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—hematologic cancer	1.65e-05	8.07e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCB1—hematologic cancer	1.65e-05	8.04e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HDC—hematologic cancer	1.65e-05	8.03e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—hematologic cancer	1.61e-05	7.84e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—hematologic cancer	1.6e-05	7.8e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOR1—hematologic cancer	1.6e-05	7.8e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTM1—hematologic cancer	1.6e-05	7.8e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—hematologic cancer	1.57e-05	7.65e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—hematologic cancer	1.53e-05	7.46e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—hematologic cancer	1.52e-05	7.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CDA—hematologic cancer	1.51e-05	7.34e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—hematologic cancer	1.49e-05	7.26e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—hematologic cancer	1.46e-05	7.14e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—hematologic cancer	1.46e-05	7.1e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—hematologic cancer	1.45e-05	7.07e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PC—hematologic cancer	1.45e-05	7.07e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTHFR—hematologic cancer	1.41e-05	6.89e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.4e-05	6.83e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GBA—hematologic cancer	1.4e-05	6.83e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—EP300—hematologic cancer	1.39e-05	6.77e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—hematologic cancer	1.39e-05	6.77e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—hematologic cancer	1.37e-05	6.67e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—hematologic cancer	1.35e-05	6.59e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—hematologic cancer	1.32e-05	6.46e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—hematologic cancer	1.28e-05	6.25e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTAP—hematologic cancer	1.28e-05	6.25e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—hematologic cancer	1.27e-05	6.17e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—hematologic cancer	1.19e-05	5.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FHL2—hematologic cancer	1.14e-05	5.57e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AGRN—hematologic cancer	1.12e-05	5.46e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—hematologic cancer	1.12e-05	5.45e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CREBBP—hematologic cancer	1.1e-05	5.37e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMMR—hematologic cancer	1.06e-05	5.17e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—IDH2—hematologic cancer	1.06e-05	5.17e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CD—hematologic cancer	1.04e-05	5.09e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—hematologic cancer	1.03e-05	5.03e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—hematologic cancer	1.03e-05	5.01e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ARNTL—hematologic cancer	9.98e-06	4.87e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3R1—hematologic cancer	9.86e-06	4.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CA9—hematologic cancer	9.71e-06	4.73e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ACP5—hematologic cancer	9.71e-06	4.73e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOR2—hematologic cancer	9.58e-06	4.67e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—IDH1—hematologic cancer	9.13e-06	4.45e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CB—hematologic cancer	9.1e-06	4.44e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TXN—hematologic cancer	9.02e-06	4.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCC3—hematologic cancer	9.02e-06	4.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTO1—hematologic cancer	9.02e-06	4.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SPHK1—hematologic cancer	8.83e-06	4.31e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UGT1A1—hematologic cancer	8.48e-06	4.14e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—hematologic cancer	8.39e-06	4.09e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC22A1—hematologic cancer	8.25e-06	4.02e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CRABP1—hematologic cancer	8.25e-06	4.02e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALOX5—hematologic cancer	8.04e-06	3.92e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—hematologic cancer	7.87e-06	3.84e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NUP98—hematologic cancer	7.79e-06	3.8e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ADCY7—hematologic cancer	7.56e-06	3.69e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOA3—hematologic cancer	7.56e-06	3.69e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NUP214—hematologic cancer	7.51e-06	3.66e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—EP300—hematologic cancer	7.5e-06	3.66e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTR—hematologic cancer	7.36e-06	3.59e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCG2—hematologic cancer	7.36e-06	3.59e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ENO2—hematologic cancer	7.21e-06	3.52e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTT1—hematologic cancer	7e-06	3.41e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SDC1—hematologic cancer	6.84e-06	3.33e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NQO1—hematologic cancer	5.81e-06	2.84e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CD44—hematologic cancer	5.81e-06	2.84e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—hematologic cancer	5.55e-06	2.71e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYCS—hematologic cancer	5.5e-06	2.68e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.47e-06	2.67e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.85e-06	2.36e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.59e-06	2.24e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—hematologic cancer	4.53e-06	2.21e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.46e-06	2.17e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.46e-06	2.17e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.94e-06	1.92e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.31e-06	1.61e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.07e-06	1.5e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.91e-06	1.42e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—hematologic cancer	2.87e-06	1.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.75e-06	1.34e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.54e-06	1.24e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—hematologic cancer	2.19e-06	1.07e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—EP300—hematologic cancer	2.09e-06	1.02e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.55e-06	7.54e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—hematologic cancer	1.26e-06	6.16e-06	CbGpPWpGaD
